|
|
|
Volumn 115, Issue , 2004, Pages 255-272
|
|
Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomas.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD20 ANTIGEN;
IODINE 131 ANTI B1 ANTIBODY;
IODINE-131 ANTI-B1 ANTIBODY;
MONOCLONAL ANTIBODY;
RADIOACTIVE IODINE;
B CELL LYMPHOMA;
CANCER STAGING;
CLASSIFICATION;
CLINICAL TRIAL;
HUMAN;
METABOLISM;
NONHODGKIN LYMPHOMA;
PATHOLOGY;
RADIOIMMUNOTHERAPY;
REMISSION;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IODINE RADIOISOTOPES;
LYMPHOMA, B-CELL;
LYMPHOMA, NON-HODGKIN;
NEOPLASM STAGING;
RADIOIMMUNOTHERAPY;
REMISSION INDUCTION;
|
|
EID: 63549141688
PISSN: 00657778
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (45)
|
